Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly

Chin Kook Rhee; Fanny Wai San Ko; Vu Van Giap; Theerasuk Kawamatawong; Jung Kyu Lee; Kazuto Matsunaga; Helmy Haja Mydin; Yong Kek Pang; Diahn Warng Perng; Myla Salazar-Supe; Yoko Shibata; David Sim; Naoya Tanabe; Augustine Tee; Hao Chien Wang; Yen Wen Wu; Faisal Yunus

doi:10.1111/resp.70103

Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly

Chin Kook Rhee
, Fanny Wai San Ko
, Vu Van Giap
, Theerasuk Kawamatawong
, Jung Kyu Lee
, Kazuto Matsunaga
, Helmy Haja Mydin
, Yong Kek Pang
, Diahn Warng Perng
, Myla Salazar-Supe
, Yoko Shibata
, David Sim
, Naoya Tanabe
, Augustine Tee
, Hao Chien Wang
, Yen Wen Wu
, Faisal Yunus

Department of Internal Medicine

Chinese University of Hong Kong
Hanoi Medical University
Bach Mai Hospital
Mahidol University
Seoul National University Boramae Hospital
Yamaguchi University
Pantai Hospital Kuala Lumpur
University of Malaya
Veterans General Hospital-Taipei
National Yang Ming Chiao Tung University
Philippine Heart Center
Fukushima Medical University
National Heart Centre Singapore
Kyoto University
Changi General Hospital
National Taiwan University
Far Eastern Memorial Hospital
Yuan Ze University
University of Indonesia

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Chronic obstructive pulmonary disease (COPD) has a high burden in Asia. These patients are also susceptible to various cardiovascular diseases (CVD). A panel of expert Asian pulmonologists explored the published literature to understand the impact of COPD and CVD on each other and to identify the cardiopulmonary risk factors in the region. The experts concluded that an elevated risk of all-cause mortality and acute cardiovascular events persists for up to 2 years following moderate and severe COPD exacerbations, with the risk of death being highest in the first 30 days after the exacerbation. High smoking rate (especially in males), high indoor and outdoor air pollution in Asia, relatively low vaccination rate in Asia (especially in low- and middle-income countries), and relatively low rate of utilisation of inhaler medications impact the cardiopulmonary risk in Asia.

Original language	English
Pages (from-to)	817-830
Number of pages	14
Journal	Respirology
Volume	30
Issue number	9
DOIs	https://doi.org/10.1111/resp.70103
State	Published - Sep 2025

Bibliographical note

Publisher Copyright:
© 2025 The Author(s). Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Asia
COPD
cardiopulmonary risk
cardiovascular disease risk
chronic obstructive pulmonary disease

Access to Document

10.1111/resp.70103

Cite this

Rhee, C. K., Ko, F. W. S., Giap, V. V., Kawamatawong, T., Lee, J. K., Matsunaga, K., Haja Mydin, H., Pang, Y. K., Perng, D. W., Salazar-Supe, M., Shibata, Y., Sim, D., Tanabe, N., Tee, A., Wang, H. C., Wu, Y. W., & Yunus, F. (2025). Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly. Respirology, 30(9), 817-830. https://doi.org/10.1111/resp.70103

@article{91d10fbc78954b56a3af0116e2c2f5e8,

title = "Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly",

abstract = "Chronic obstructive pulmonary disease (COPD) has a high burden in Asia. These patients are also susceptible to various cardiovascular diseases (CVD). A panel of expert Asian pulmonologists explored the published literature to understand the impact of COPD and CVD on each other and to identify the cardiopulmonary risk factors in the region. The experts concluded that an elevated risk of all-cause mortality and acute cardiovascular events persists for up to 2 years following moderate and severe COPD exacerbations, with the risk of death being highest in the first 30 days after the exacerbation. High smoking rate (especially in males), high indoor and outdoor air pollution in Asia, relatively low vaccination rate in Asia (especially in low- and middle-income countries), and relatively low rate of utilisation of inhaler medications impact the cardiopulmonary risk in Asia.",

keywords = "Asia, COPD, cardiopulmonary risk, cardiovascular disease risk, chronic obstructive pulmonary disease",

author = "Rhee, \{Chin Kook\} and Ko, \{Fanny Wai San\} and Giap, \{Vu Van\} and Theerasuk Kawamatawong and Lee, \{Jung Kyu\} and Kazuto Matsunaga and \{Haja Mydin\}, Helmy and Pang, \{Yong Kek\} and Perng, \{Diahn Warng\} and Myla Salazar-Supe and Yoko Shibata and David Sim and Naoya Tanabe and Augustine Tee and Wang, \{Hao Chien\} and Wu, \{Yen Wen\} and Faisal Yunus",

note = "Publisher Copyright: {\textcopyright} 2025 The Author(s). Respirology published by John Wiley \& Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.",

year = "2025",

month = sep,

doi = "10.1111/resp.70103",

language = "English",

volume = "30",

pages = "817--830",

journal = "Respirology",

issn = "1323-7799",

publisher = "John Wiley and Sons Inc.",

number = "9",

}

Rhee, CK, Ko, FWS, Giap, VV, Kawamatawong, T, Lee, JK, Matsunaga, K, Haja Mydin, H, Pang, YK, Perng, DW, Salazar-Supe, M, Shibata, Y, Sim, D, Tanabe, N, Tee, A, Wang, HC, Wu, YW & Yunus, F 2025, 'Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly', Respirology, vol. 30, no. 9, pp. 817-830. https://doi.org/10.1111/resp.70103

TY - JOUR

T1 - Management of COPD With Cardiovascular Risk in Asia

T2 - A Review by the Asian Pacific Society of Respirology COPD Assembly

AU - Rhee, Chin Kook

AU - Ko, Fanny Wai San

AU - Giap, Vu Van

AU - Kawamatawong, Theerasuk

AU - Lee, Jung Kyu

AU - Matsunaga, Kazuto

AU - Haja Mydin, Helmy

AU - Pang, Yong Kek

AU - Perng, Diahn Warng

AU - Salazar-Supe, Myla

AU - Shibata, Yoko

AU - Sim, David

AU - Tanabe, Naoya

AU - Tee, Augustine

AU - Wang, Hao Chien

AU - Wu, Yen Wen

AU - Yunus, Faisal

PY - 2025/9

Y1 - 2025/9

N2 - Chronic obstructive pulmonary disease (COPD) has a high burden in Asia. These patients are also susceptible to various cardiovascular diseases (CVD). A panel of expert Asian pulmonologists explored the published literature to understand the impact of COPD and CVD on each other and to identify the cardiopulmonary risk factors in the region. The experts concluded that an elevated risk of all-cause mortality and acute cardiovascular events persists for up to 2 years following moderate and severe COPD exacerbations, with the risk of death being highest in the first 30 days after the exacerbation. High smoking rate (especially in males), high indoor and outdoor air pollution in Asia, relatively low vaccination rate in Asia (especially in low- and middle-income countries), and relatively low rate of utilisation of inhaler medications impact the cardiopulmonary risk in Asia.

AB - Chronic obstructive pulmonary disease (COPD) has a high burden in Asia. These patients are also susceptible to various cardiovascular diseases (CVD). A panel of expert Asian pulmonologists explored the published literature to understand the impact of COPD and CVD on each other and to identify the cardiopulmonary risk factors in the region. The experts concluded that an elevated risk of all-cause mortality and acute cardiovascular events persists for up to 2 years following moderate and severe COPD exacerbations, with the risk of death being highest in the first 30 days after the exacerbation. High smoking rate (especially in males), high indoor and outdoor air pollution in Asia, relatively low vaccination rate in Asia (especially in low- and middle-income countries), and relatively low rate of utilisation of inhaler medications impact the cardiopulmonary risk in Asia.

KW - Asia

KW - COPD

KW - cardiopulmonary risk

KW - cardiovascular disease risk

KW - chronic obstructive pulmonary disease

UR - https://www.scopus.com/pages/publications/105012760169

U2 - 10.1111/resp.70103

DO - 10.1111/resp.70103

M3 - Review article

C2 - 40785398

AN - SCOPUS:105012760169

SN - 1323-7799

VL - 30

SP - 817

EP - 830

JO - Respirology

JF - Respirology

IS - 9

ER -

Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this